SCHEMBL19081726

SCHEMBL19081726

c1ccc2c(c1)ccc1c3cc(-c4c5ccccc5c(-c5ccc6c(c5)sc5ccccc56)c5ccccc45)c4c5ccccc5oc4c3oc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ARSA P15289 1/20 0.33
CDC25A P30304 1/20 0.33
CDC25C P30307 1/20 0.33
CYP1A1 P04798 10/20 0.32
CYP1B1 Q16678 10/20 0.32
CYP1A2 P05177 9/20 0.31
PRKDC P78527 2/20 0.31
PSMD14 O00487 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
CSNK2A1 P68400 1/20 0.31
XDH P47989 1/20 0.31
ALDH1A1 P00352 4/20 0.31
KDM4E B2RXH2 3/20 0.31
HPGD P15428 3/20 0.31
MAPT P10636 3/20 0.31
HSD17B10 Q99714 2/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932194 0.90 ALDH1A1 (0.35) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL19081472 0.87 CYP1A1 (0.43) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL19081708 0.86 TDP1 (0.36) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL17931994 0.85 ALOX5 (0.39) TDP1L3MBTL1PRKDCALDH1A1KDM4E
SCHEMBL19081724 0.84 CYP1A1 (0.34) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL19081490 0.84 CYP1A1 (0.39) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL17931990 0.84 CYP1A1 (0.38) TDP1L3MBTL1CYP1A1CYP1B1CYP1A2
SCHEMBL17932214 0.83 ALOX5 (0.35) PRKDCALOX5
SCHEMBL19081711 0.82 CYP1A1 (0.35) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL19081583 0.82 CYP1A1 (0.43) TDP1L3MBTL1ARSACDC25ACDC25C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ARSA 4543/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ARSA 4543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.